20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Chemistry Behind Ticagrelor: Understanding Key Intermediates and Their Synthesis

The development of advanced pharmaceuticals is a testament to the intricate world of organic chemistry and sophisticated synthesis pathways. Ticagrelor, a vital antiplatelet medication, is no exception. Its complex molecular structure is built step-by-step using specialized chemical intermediates. NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role in this process by supplying high-quality Ticagrelor intermediates, enabling efficient and reliable API manufacturing.

Understanding the synthesis of Ticagrelor involves appreciating the role of each intermediate. For instance, Ticagrelor Intermediate (CAS 274693-27-5) is a foundational component, critical for assembling the core structure of the final drug. Pharmaceutical companies often look for trusted Ticagrelor intermediate suppliers that can provide detailed technical data and assurance of purity, which is precisely what NINGBO INNO PHARMCHEM CO.,LTD. offers.

The process of synthesizing such intermediates requires advanced chemical knowledge, precise control over reaction conditions, and stringent quality checks. NINGBO INNO PHARMCHEM CO.,LTD. invests heavily in its research and development capabilities and manufacturing facilities to ensure that our intermediates meet the high standards expected by the pharmaceutical industry. When you choose to buy Ticagrelor intermediate online from us, you are investing in quality and expertise.

The efficiency of the synthesis pathway directly impacts the cost-effectiveness and environmental footprint of drug production. By providing a highly pure and readily usable Ticagrelor synthesis raw material, we help our clients streamline their manufacturing processes. This focus on intermediate quality is fundamental to producing effective and safe pharmaceutical intermediates for cardiovascular drugs.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to advancing pharmaceutical synthesis through the reliable provision of essential chemical building blocks. Our expertise in producing high-purity intermediates like the one for Ticagrelor underscores our dedication to supporting the global healthcare sector.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Global Supply Chain Dynamics for Ticagrelor Intermediates: Challenges and Opportunities

Next: Regulatory Compliance in Pharmaceutical Intermediates: The Case of Ticagrelor Intermediates

All Rights Reserved